Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients
浆细胞样树突状细胞、Slan+-单核细胞和自然杀伤细胞计数可作为血细胞生物标志物,用于预测非小细胞肺癌患者对免疫检查点抑制剂单药治疗的反应
期刊:Cancers
影响因子:
doi:10.3390/cancers15215285
Francesca Pettinella, Chiara Lattanzi, Marta Donini, Elena Caveggion, Olivia Marini, Giulia Iannoto, Sara Costa, Elena Zenaro, Tiago Moderno Fortunato, Sara Gasperini, Matteo Giani, Lorenzo Belluomini, Marco Sposito, Jessica Insolda, Ilaria Mariangela Scaglione, Michele Milella, Annalisa Adamo, Orne
信号转导
免疫
肿瘤
肺癌
单核细胞
树突状细胞
自然杀伤细胞
Checkpoint